VistaGen Therapeutics
VTGN
VTGN
47 hedge funds and large institutions have $45.3M invested in VistaGen Therapeutics in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
77% less call options, than puts
Call options by funds: $370K | Put options by funds: $1.64M
Holders
47
Holding in Top 10
–
Calls
$370K
Puts
$1.64M
Top Buyers
| 1 | +$491K | |
| 2 | +$378K | |
| 3 | +$103K | |
| 4 |
Millennium Management
New York
|
+$76.3K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$64K |
Top Sellers
| 1 | -$2.57M | |
| 2 | -$1.04M | |
| 3 | -$926K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$95.1K |
| 5 |
Barclays
London,
United Kingdom
|
-$67K |